We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Devices, MIMETAS Sign Co-marketing Agreement

News   Feb 06, 2017 | Original story from MIMETAS

 
Molecular Devices, MIMETAS Sign Co-marketing Agreement
 
 
 

RELATED ARTICLES

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

Super-resolution Microscopy at its Best

News

Does expansion microscopy deliver true-to-life images of cell structures? A new publication shows for the first time that the method actually works reliably.

READ MORE

3D Printed Microfluidic Device Simulates Cancer Treatments

News

Inexpensive 3-D-printed microfluidics device could be used to personalize cancer treatment. A key feature in this MIT-designed device was using a new biocompatible resin — traditionally used for dental applications — that can support long-term survival of biopsied tissue.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE